CAR T-Cell Therapy in R/R LBCL: TRANSFORM, ZUMA-7, and PILOT Studies

In the context of CAR T-cell therapy, Manali Kamdar, MD, reviews TRANSFORM, ZUMA-7, and PILOT trials in the treatment of patients with relapsed-refractory (R/R) large B-cell lymphoma (LBCL).

EP: 1.Overview of Large B-Cell Lymphoma (LBCL)

Now Viewing

EP: 2.CAR T-Cell Therapy in R/R LBCL: TRANSFORM, ZUMA-7, and PILOT Studies

EP: 3.Treatment Strategies for Patients with R/R LBCL

EP: 4.CAR T-Cell Therapy as Second-Line Treatment in LBCL

EP: 5.Choosing the Appropriate CAR T-Cell Therapy in Patients with R/R DLBCL

EP: 6.Additional Key Data Updates from ASH 2022 on Treatment of LBCL

EP: 7.Treatment Sequencing in LBCL: Clinical Trial and Real-World Data

EP: 8.Practice Pearls for Physicians Considering CAR T-cell Therapy for Patients with LBCL

Recent Videos